M&A Activity • Mar 31, 2015
M&A Activity
Open in ViewerOpens in native device viewer
News Details
Corporate | 31 March 2015 15:14
MPH Mittelständische Pharma Holding AG: purchase of the majority of the equity of CR Capital Real Estate
MPH Mittelständische Pharma Holding AG / Key word(s): Investment
2015-03-31 / 15:14
MPH Mittelständische Pharma Holding AG:
Announcement of the purchase of the majority of the equity of the company CR Capital Real Estate, Berlin.
The company MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0L1H32), announces the purchase of the majority of the equity of the company CR Capital Real Estate AG, Berlin (ISIN: DE000A0WMQ53).
Already in 2014 we used the attractive pricing of the share, according to our assessment, for an acquisition above the level of 25%. The value and price of the investment developed very positive and motivated us to further increase the holding. MPH owns now more than 50% of the shares. We see further potential for CR Capital Real Estate AG, especially in the segment of healthcare properties, which provide attractive value development with independence from economic cycles.
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth markets Pharma and Healthcare. The pharmaceutical sector makes a contribution towards cutting costs in the healthcare system with medicines manufactured on the basis of patent-free and patent-protected active substances for the therapy of chronic diseases. The field of healthcare offers healthcare preparations, individual patient therapies, aesthetic surgeries and other medical treatments.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 42,813,842
Listed shares: ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Stock symbol: 93M
Contact: Linda Reichelt
MPH Mittelständische Pharma Holding AG
Fasanenstraße 77
D-10623 Berlin
Phone:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669
E-Mail: [email protected] Web: www.mph-ag.de
2015-03-31 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MPH Mittelständische Pharma Holding AG |
| Fasanenstraße 77 | |
| 10623 Berlin | |
| Germany | |
| Phone: | 030 / 897 308 660 |
| Fax: | 030 / 897 308 669 |
| E-mail: | [email protected] |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A0L1H32 |
| WKN: | A0L1H3 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt |
| End of News | DGAP News-Service |
| - - - |
| 340087 2015-03-31 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.